New England Journal of Medicine Q1 Unclaimed
The New England Journal of Medicine (NEJM) is the world’s leading medical journal and website. Published continuously for over 200 years, NEJM delivers high-quality, peer-reviewed research and interactive clinical content to physicians, educators, and the global medical community. Our mission is to bring physicians the best research and information at the intersection of biomedical science and clinical practice and to present this information in understandable and clinically useful formats It has an SJR impact factor of 19,889.
New England Journal of Medicine focuses its scope in these topics and keywords: patients, treatment, care, therapy, virus, medical, trial, coronary, chronic, clinical, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
0 €
Inmediate OA- €
Embargoed OA- €
Non OAMetrics
19,889
SJR Impact factor1030
H Index1671
Total Docs (Last Year)4312
Total Docs (3 years)15715
Total Refs82469
Total Cites (3 years)1842
Citable Docs (3 years)19,08
Cites/Doc (2 years)9,40
Ref/DocOther journals with similar parameters
Nature Reviews Drug Discovery Q1
Annual Review of Pathology: Mechanisms of Disease Q1
NCHS data brief Q1
Molecular Systems Biology Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus
16119 Citations View moreClinical Characteristics of Coronavirus Disease 2019 in China
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
11248 Citations View moreA Novel Coronavirus from Patients with Pneumonia in China, 2019
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome
7570 Citations View moreUse of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
Sorafenib in Advanced Hepatocellular Carcinoma
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
Intensive Insulin Therapy in Critically Ill Patients
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock
Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection
The Occurrence of Sleep-Disordered Breathing among Middle-Aged Adults
Beneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
5986 Citations View more
If you are a journal editor you can claim the journal profile and add new information for the visitors.
Comments